Critical Role of Dysregulated Autophagy in Pathophysiology of Podocytopathy
Kidney360 · 2026-09 · 7 (9) · 2149-2159
DOI: 10.34067/kid.0000001152 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney360, online erschienen am 16.04.2026. Verfasst von Claudio Ponticelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, Milan, Italy. Hauptthemen laut MEDLINE: Podocytes, Autophagy. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Podocytopathies are glomerular disorders characterized by podocyte injury, typically resulting in marked proteinuria. Podocytes are highly specialized, terminally differentiated epithelial cells essential for maintaining the structural and functional integrity of the glomerular filtration barrier. Owing to constant exposure to injurious stimuli, podocytes may undergo dedifferentiation, hypertrophy, apoptosis, or necrosis. Autophagy is a key cytoprotective mechanism that enables cells to degrade and recycle damaged or unnecessary components through a multistep process involving induction, autophagosome formation, fusion with lysosomes, and degradation. Under physiologic conditions, podocytes exhibit high basal levels of autophagy, which are essential for clearing aberrant cytoplasmic elements, including inflammasomes. Both experimental and clinical studies have demonstrated that dysregulated autophagy is a common feature in various podocytopathies, including minimal change disease, FSGS, membranous nephropathy, diabetic nephropathy, and lupus nephritis. Restoration of autophagic activity through natural or pharmacologic inducers—such as mechanistic target of rapamycin inhibitors, metformin, or mineralocorticoid receptor antagonists—has been associated with reduced proteinuria and improved podocyte function. Despite strong preclinical evidence, clinical trials investigating autophagy-targeting therapies in podocytopathies remain limited and often lack long-term follow-up. Moreover, the clinical use of some promising agents is constrained by significant adverse effects, underscoring the need for safer, more targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Independent Researcher, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy.
- Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
- Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, Florida.
- Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.
ORCID-Profile: Gabriella Moroni, Alessia Fornoni
Zitieren
APA
Ponticelli, C., Moroni, G., Calatroni, M., Njeim, R., & Fornoni, A. (2026). Critical Role of Dysregulated Autophagy in Pathophysiology of Podocytopathy. Kidney360, 7(9), 2149-2159. https://doi.org/10.34067/kid.0000001152
Vancouver
Ponticelli C, Moroni G, Calatroni M, Njeim R, Fornoni A. Critical Role of Dysregulated Autophagy in Pathophysiology of Podocytopathy. Kidney360. 2026;7(9):2149-2159. doi:10.34067/kid.0000001152
BibTeX
@article{Ponticelli2026,
author = {Ponticelli, Claudio and Moroni, Gabriella and Calatroni, Marta and Njeim, Rachel and Fornoni, Alessia},
title = {Critical Role of Dysregulated Autophagy in Pathophysiology of Podocytopathy},
journal = {Kidney360},
year = {2026},
volume = {7},
number = {9},
pages = {2149--2159},
doi = {10.34067/kid.0000001152}
}
EUVIMED